Compounds > fe(iii)-edta
Page last updated: 2024-08-23

fe(iii)-edta and Bladder Cancer

fe(iii)-edta has been researched along with Bladder Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buxton, PJ1

Trials

1 trial(s) available for fe(iii)-edta and Bladder Cancer

ArticleYear
Short communication: the use of sodium ironedetate (Sytron) as an MRI rectal contrast agent.
    The British journal of radiology, 1996, Volume: 69, Issue:819

    Topics: Administration, Rectal; Contrast Media; Edetic Acid; Ferric Compounds; Humans; Magnetic Resonance Imaging; Male; Prostatic Neoplasms; Urinary Bladder Neoplasms

1996